
Safety Efforts in Pediatric Drug Development
작성자
Conor D. Byrne
아직 평점이 없습니다
Children’s
형식
하드커버
페이지
133
언어
슬로베니아어
출판됨
Jun 1, 2009
출판사
Nova Science Pub Inc
판
1
ISBN-10
1607415658
ISBN-13
9781607415657
설명
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.